We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTM
2076
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$8K ﹤0.01%
839
– –
MEET
2077
DELISTED
The Meet Group, Inc. Common Stock
MEET
$8K ﹤0.01%
+1,710
New +$8.04K
WPG
2078
DELISTED
Washington Prime Group Inc.
WPG
$8K ﹤0.01%
271
+83
+44% +$3.01K
AKO.B icon
2079
Embotelladora Andina Series B
AKO.B
$4.69B
$7K ﹤0.01%
418
– –
ALE
2080
DELISTED
Allete
ALE
$7K ﹤0.01%
98
– –
ANDE icon
2081
Andersons Inc
ANDE
$2.49B
$7K ﹤0.01%
302
+141
+88% +$3.08K
ANIK icon
2082
Anika Therapeutics
ANIK
$202M
$7K ﹤0.01%
149
+50
+51% +$2.9K
ARCB icon
2083
ArcBest
ARCB
$3.33B
$7K ﹤0.01%
274
-47
-15% -$1.36K
ARR
2084
Armour Residential REIT
ARR
$2.04B
$7K ﹤0.01%
87
+52
+149% +$4.44K
BJ icon
2085
BJs Wholesale Club
BJ
$12.4B
$7K ﹤0.01%
335
+108
+48% +$2.67K
BSAC icon
2086
Banco Santander Chile
BSAC
$16B
$7K ﹤0.01%
316
– –
BZUN
2087
Baozun
BZUN
$168M
$7K ﹤0.01%
226
-12
-5% -$476
CDP icon
2088
COPT Defense Properties
CDP
$4.34B
$7K ﹤0.01%
267
+111
+71% +$3.24K
CHCT
2089
Community Healthcare Trust
CHCT
$543M
$7K ﹤0.01%
166
+43
+35% +$1.96K
CLDT
2090
Chatham Lodging
CLDT
$638M
$7K ﹤0.01%
397
+219
+123% +$3.95K
CTS icon
2091
CTS Corp
CTS
$1.85B
$7K ﹤0.01%
260
+124
+91% +$3.59K
CUBI icon
2092
Customers Bancorp
CUBI
$2.69B
$7K ﹤0.01%
303
-15
-5% -$345
DAN icon
2093
Dana Inc
DAN
$2.95B
$7K ﹤0.01%
400
-473
-54% -$7.89K
DNOW icon
2094
DNOW Inc
DNOW
$2.53B
$7K ﹤0.01%
674
-389
-37% -$4.34K
DXPE icon
2095
DXP Enterprises
DXPE
$2.49B
$7K ﹤0.01%
191
– –
EGAN icon
2096
eGain
EGAN
$190M
$7K ﹤0.01%
1,000
– –
ENTA icon
2097
Enanta Pharmaceuticals
ENTA
$367M
$7K ﹤0.01%
114
-66
-37% -$4.09K
GFF icon
2098
Griffon
GFF
$4.29B
$7K ﹤0.01%
382
+137
+56% +$2.88K
GOOS
2099
Canada Goose Holdings
GOOS
$903M
$7K ﹤0.01%
200
– –
GPMT
2100
Granite Point Mortgage Trust
GPMT
$63.3M
$7K ﹤0.01%
408
– –
82 83
84
85 86

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.